Persistent supravenous erythematous eruption-like changes from antibiotics.
作者信息
Hashimoto Takashi, Watanabe Risa, Satoh Takahiro
机构信息
Department of Dermatology, National Defense Medical College, Tokorozawa, Japan.
出版信息
J Dermatol. 2016 Sep;43(9):1093-4. doi: 10.1111/1346-8138.13351. Epub 2016 Mar 30.
PMID:27028124
Abstract
摘要
相似文献
1
Persistent supravenous erythematous eruption-like changes from antibiotics.
J Dermatol. 2016 Sep;43(9):1093-4. doi: 10.1111/1346-8138.13351. Epub 2016 Mar 30.
2
Acute generalized exanthematous pustulosis: a rare clinical entity with use of piperacillin/tazobactam.
Am J Ther. 2009 Nov-Dec;16(6):591-2. doi: 10.1097/MJT.0b013e31818d5f6d.
3
Pustular eruption in the ICU.
Am J Med. 2012 Aug;125(8):758-60. doi: 10.1016/j.amjmed.2012.04.029.
4
Piperacillin/tazobactam--induced petechial rash.
Ann Pharmacother. 2010 Jul-Aug;44(7-8):1345-6. doi: 10.1345/aph.1P247. Epub 2010 Jun 22.
5
Fixed drug eruption caused by piperacillin-tazobactam.
J Investig Allergol Clin Immunol. 2013;23(2):132-3.
6
A vesiculobullous eruption in a hospitalized patient. Diagnosis: Drug-induced linear IgA bullous dermatosis (LAD) with eosinophils.
Arch Dermatol. 2011 Dec;147(12):1443, 1448. doi: 10.1001/archderm.147.12.1443-c.
7
Piperacillin-Tazobactam-induced Adverse Drug Events in Pediatric Patients on Outpatient Parenteral Antimicrobial Therapy.
Pediatr Infect Dis J. 2017 Jan;36(1):50-52. doi: 10.1097/INF.0000000000001351.
8
Ultraviolet recall-like phenomenon occurring after piperacillin, tobramycin, and ciprofloxacin therapy.
J Am Acad Dermatol. 2001 Jun;44(6):1045-7. doi: 10.1067/mjd.2001.113457.
9
Generalized fixed drug eruption to piperacillin/tazobactam and review of literature.
Dermatol Online J. 2018 Apr 15;24(4):13030/qt8cr714g5.
10
Kounis Syndrome induced by intravenous administration of piperacillin/tazobactam: a case report.
Int J Cardiol. 2012 Mar 22;155(3):e42-4. doi: 10.1016/j.ijcard.2011.07.049. Epub 2011 Aug 11.
Zotero 插件